Miao Liu
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies 3
-
- Peptidase Inhibition and Analysis 4
- HER2/EGFR in Cancer Research 3
- Lymphatic System and Diseases 2
- Cancer Cells and Metastasis 2
-
- Protein Degradation and Inhibitors 6
- Ubiquitin and proteasome pathways 4
-
- Multiple Myeloma Research and Treatments 2
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Miao Liu
30 papers receiving 417 citations
Peers
Comparison fields: 5 of 94
- Modeling and Simulation 78
- Oncology 124
- Cancer Research 56
- Molecular Biology 169
- Endocrinology, Diabetes and Metabolism 39
Countries citing papers authored by Miao Liu
This map shows the geographic impact of Miao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miao Liu more than expected).
Fields of papers citing papers by Miao Liu
This network shows the impact of papers produced by Miao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miao Liu. The network helps show where Miao Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Miao Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 16 | |
| 8 | 2023 | 20 | |
| 9 | 2022 | 44 | |
| 10 | 2022 | 9 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 4 | |
| 13 | 2022 | 27 | |
| 14 | 2021 | 1 | |
| 15 | 2021 | 8 | |
| 16 | 2020 | 1 | |
| 17 | 2020 | 33 | |
| 18 | 2020 | 94 | |
| 19 | 2018 | 23 | |
| 20 | 2012 | 26 |
About Miao Liu
Miao Liu is a scholar working on Oncology, Modeling and Simulation and Cancer Research, having authored 33 papers that have together received 420 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (6 papers), Peptidase Inhibition and Analysis (4 papers), Ubiquitin and proteasome pathways (4 papers), HER2/EGFR in Cancer Research (3 papers), COVID-19 epidemiological studies (3 papers), Multiple Myeloma Research and Treatments (2 papers), Lymphatic System and Diseases (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Modeling and Simulation (78 citations), Oncology (124 citations) and Cancer Research (56 citations). Miao Liu has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Mengyuan Dai, Rui Li, Ruirong Tan, Yuying Shi, Yuxin Gao, Qiu Li, Zhenya Yang, Hongru Liu, Gang Fan and Can Küçük. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.